Loading organizations...
§ Private Profile · Zürich, Zurich, Switzerland
Developer of small molecules targeting drug resistance in cancer therapy.
TOLREMO therapeutics has raised $54.9M across 4 funding rounds.
TOLREMO therapeutics has raised $54.9M in total across 4 funding rounds.
TOLREMO therapeutics has raised $54.9M across 4 funding rounds. Most recently, it raised $38.0M Series A in September 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 20, 2023 | $38M Series A | BioMedPartners | Francesco Hofmann | Announced |
| Jun 10, 2020 | $5M Series A Plus | Altos Ventures, BioMedPartners | Redalpine, Z%C3%BCrcher%20Kantonalbank | Announced |
| Sep 24, 2018 | $9.4M Series A | Andreas Wallnoefer | Altos Ventures, Redalpine, Z%C3%BCrcher%20Kantonalbank | Announced |
| Sep 19, 2017 | $2.5M Venture Round | — | — | Announced |
TOLREMO therapeutics has raised $54.9M in total across 4 funding rounds.
TOLREMO therapeutics's investors include BioMedPartners, Francesco Hofmann, Altos Ventures, Redalpine, Z%C3%BCrcher%20Kantonalbank, Andreas Wallnoefer.